Podcasts about dizon

On the inaugural episode of ASCO Education: By the Book, Dr. Nathan Pennell and Dr. Don Dizon share reflections on the evolution of the ASCO Educational Book, its global reach, and the role of its new companion podcast to further shine a spotlight on the issues shaping the future of modern oncology. TRANSCRIPT Dr. Nathan Pennell: Hello, I'm Dr. Nate Pennell, welcoming you to the first episode of our new podcast, ASCO Education: By the Book. The podcast will feature engaging discussions between editors and authors from the ASCO Educational Book. Each month, you'll hear nuanced views on key topics in oncology featured in Education Sessions at ASCO meetings, as well as some deep dives on the advances shaping modern oncology. Although I am honored to serve as the editor-in-chief (EIC) of the ASCO Educational Book, in my day job, I am the co-director of the Cleveland Clinic Lung Cancer Program and vice chair for clinical research for the Taussig Cancer Center here in Cleveland. I'm delighted to kick off our new podcast with a discussion featuring the Ed Book's previous editor-in-chief. Dr. Don Dizon is a professor of medicine and surgery at Brown University and works as a medical oncologist specializing in breast and pelvic malignancies at Lifespan Cancer Institute in Rhode Island. Dr. Dizon also serves as the vice chair for membership and accrual at the SWOG Cancer Research Network. Don, it's great to have you here for our first episode of ASCO Education: By the Book. Dr. Don Dizon: Really nice to be here and to see you again, my friend. Dr. Nathan Pennell: This was the first thing I thought of when we were kicking off a podcast that I thought we would set the stage for our hopefully many, many listeners to learn a little bit about what the Ed Book used to be like, how it has evolved over the last 14 years or so since we both started here and where it's going. You started as editor-in-chief in 2012, is that right? Dr. Don Dizon: Oh, boy. I believe that is correct, yes. I did two 5-year stints as EIC of the Educational Book, so that sounds about right. Although you're aging me very clearly on this podcast. Dr. Nathan Pennell: I had to go back in my emails to see if I could figure out when we started on this because we've been working on it for some time. Start out a little bit by telling me what do you remember about the Ed Book from back in the day when you were applying to be editor-in-chief and thinking about the Ed Book. What was it like at that time? Dr. Don Dizon: You know, it's so interesting to think about it.  Ten years ago, we were both in a very different place in our careers, and I remember when the Ed Book position came up, I had been writing a column for ASCO. I had done some editorial activities with other journals for sure, but what always struck me was it was very unclear how one was chosen to be a part of the education program at ASCO. And then it was very unclear how those faculty were then selected to write a paper for the Educational Book. And it was back in the day when the Educational Book was completely printed. So, there was this book that was cherished among American fellows in oncology. And it was one that, when I was newly attending, and certainly two or three years before the editor's position came up, it was one that I referenced all the time. So, it was a known commodity for many of us. And there was a certain sense of selectivity about who was invited to write in it. And it wasn't terribly transparent either. So, when the opportunity to apply for editor-in-chief of the Educational Book came up, I had already been doing so much work for ASCO. I had been on the planning committees and served in many roles across the organization, and editing was something I found I enjoyed in other work. So, I decided to put my name in the ring with the intention of sort of bringing the book forward, getting it indexed, for example, so that there was this credit that was more than just societal credit at ASCO. This ended up being something that was referenced and acknowledged as an important paper through PubMed indexing. And then also to provide it as a space where we could be more transparent about who was being invited and broadening the tent as to who could participate as an author in the Ed Book. Dr. Nathan Pennell: It's going to be surprising to many of our younger listeners to learn that the Educational Book used to be just this giant, almost like a brick. I mean, it was this huge tome of articles from the Education Sessions that you got when you got your meeting abstracts book at the annual meeting. And you can always see people on the plane on the way out of Chicago with their giant books. Dr. Don Dizon: Yes. Dr. Nathan Pennell: That added lots of additional weight to the plane, I'm sure, on the way out. Dr. Don Dizon: And it was not uncommon for us to be sitting at an airport, and people would be reading those books with highlighters. Dr. Nathan Pennell: I fondly remember being a fellow and coming up and the Ed Book was always really important to me, so I was excited. We'll also let the listeners in on that. I also applied to be the original editor-in-chief of the Ed Book back in 2012, although I was very junior and did not have any real editorial experience. I think I may have been section editor for The Oncologist at that point. And I had spoken to Dr. Ramaswamy Govindan at WashU who had been the previous editor-in-chief about applying and he was like, “Oh yeah. You should absolutely try that out.” And then when Dr. Dizon was chosen, I was like, “Oh, well. I guess I didn't get it.” And then out of the blue I got a call asking me to join as the associate editor, which I was really always very thankful for that opportunity. Dr. Don Dizon: Well, it was a highly fruitful collaboration, I think, between you and I when we first started. I do remember taking on the reins and sort of saying, “You know, this is our vision of what we want to do.” But then just working with the authors, which we did, about how to construct their papers and what we were looking for, all of that is something I look back really fondly on. Dr. Nathan Pennell: I think it was interesting too because neither one of us had really a lot of transparency into how things worked when we started. We kind of made it up a little bit as we went along. We wanted to get all of the faculty, or at least as many of them as possible contributing to these. And we would go to the ASCO Education Committee meeting and kind of talk about the Ed Book, and we were thinking about, you know, how could we get people to submit. So, at the time it wasn't PubMed indexed. Most people, I think, submitted individual manuscripts just from their talk, which could be anywhere from full length review articles to very brief manuscripts. Dr. Don Dizon: Sometimes it was their slides with like a couple of comments on it. Dr. Nathan Pennell: And some of them were almost like a summary of the talk. Yeah, exactly. And so sort of making that a little more uniform. There was originally an honorarium attached, which went away, but I think PubMed indexing was probably the biggest incentive for people to join. I remember that was one of the first things you really wanted to get. Dr. Don Dizon Yeah. And, you know, it was fortuitous. I'd like to take all the credit for it, but ASCO was very forward thinking with Dr. Ramaswamy and the conversations about going to PubMed with this had preceded my coming in. We knew what we needed to do to get this acknowledged, which was really strengthening the peer review so that these papers could meet the bar to get on PubMed. But you know, within the first, what, two or three years, Nate, of us doing this, we were able to get this accepted. And now it is. If you look at what PubMed did for us, it not only increased the potential of who was going to access it, but for, I think the oncology community, it allowed people access to papers by key opinion leaders that was not blocked by a paywall. And I thought that was just super important at the time. Social media was something, but it wasn't what it is now. But anybody could access these manuscripts and it's still the case today. Dr. Nathan Pennell: I think it's hard to overstate how important that was. People don't realize this, but the Ed Book is really widely accessed, especially outside the US as well. And a lot of people who can't attend the meeting to get the print, well, the once print, book could actually get access to essentially the education session from the annual meeting without having to fly all the way to the US to attend. Now, you know, we have much better virtual meeting offerings now and whatnot. But at the time it was pretty revolutionary to be able to do that. Dr. Don Dizon: Yeah, and you know, it's so interesting when I think back to, you know, this sort of evolution to a fully online publication of the Ed Book. It was really some requests from international participants of the annual meeting who really wanted to continue to see this in print. At that time, it was important to recognize that access to information was not uniform across the world. And people really wanted that print edition, maybe not for themselves, but so that access in more rural areas or where access in the broadband networks were not established that they still could access the book. I think things have changed now. We were able, I think, in your tenure, to see it fully go online. But even I just remember that being a concern as we went forward. Dr. Nathan Pennell: Yeah, we continued with the print book that was available if people asked for it, but apparently few enough people asked for it that it moved fully online. One of the major advantages of being fully online now is of course, it does allow us to publish kind of in real time as the manuscripts come out in the months leading up to the meeting, which has been, I think, a huge boon because it can build momentum for the Education Sessions coming in. People, you know, really look forward to it. Dr. Don Dizon: Yeah, that was actually a concern, you know, when we were phasing out Ed Book and going to this continuous publication model where authors actually had the ability to sort of revise their manuscript and that would be automatically uploaded. You had a static manuscript that was fully printed, and it was no longer an accurate one. And we did have the ability to fix it. And it just goes to show exactly what you're saying. This idea that these are living papers was really an important thing that ASCO embraced quite early, I think. Dr. Nathan Pennell: And with the onset of PubMed indexing, the participation from faculty skyrocketed and almost within a couple of years was up to the vast majority of sessions and faculty participating. Now I think people really understand that this is part of the whole process. But at the time I remember writing out on my slides in all caps, “THIS IS AN EXPECTATION.” And that's about the best word I could give because I asked if we could make people do it, and they were like, no, you can't make people do it. Dr. Don Dizon: So right.  Actually, I don't think people are aware of the work on the back end every year when I was on as EIC, Nate and myself, and then subsequently Dr. Hope Rugo would have these informational sessions with the education faculty and we would tout the Ed Book, tout the expectation, tout it was PubMed indexed and tout multidisciplinary participation. So, we were not seeing four manuscripts reflecting one session. You know, this encouragement to really embrace multidisciplinary care was something that very early on we introduced and really encouraged people not to submit perspective manuscripts, but to really get them in and then harmonize the paper so that it felt like it was, you know, one voice. Dr. Nathan Pennell: I consider that after PubMed indexing, the next major change to the Ed Book, that really made it a better product and that was moving from, you know, just these short individual single author manuscripts to single session combined manuscript that had multiple perspectives and topics, really much more comprehensive review articles. And I don't even remember what the impetus was for that, but it was really a success. Dr. Don Dizon: Yeah, I mean, I think in the beginning it was more of a challenge, I think, because people were really not given guidance on what these papers were supposed to look like. So, we were seeing individual manuscripts come forward. Looking back, it really foreshadowed the importance of multidisciplinary management. But at the time, it was really more about ensuring that people were leaving the session with a singular message of what to do when you're in clinic again. And the goal was to have the manuscripts reflect that sort of consensus view of a topic that was coming in. There were certain things that people still argued would not fit in a multidisciplinary manuscript. You know, if you have someone who's writing and whose entire talk was on the pathology of thyroid cancer. Another topic was on survivorship after thyroid cancer. It was hard to sort of get those two to interact and cover what was being covered. So, we were still getting that. But you're right, at the end of my tenure and into yours, there were far fewer of those individual manuscripts. Dr. Nathan Pennell: And I think it's even made it easier to write because now, you know, you just have to write a section of a manuscript and not put together an entire review. So, it has helped with getting people on board. Dr. Don Dizon: Well, the other thing I thought was really interesting about the process is when you're invited to do an Education Session at ASCO, you're either invited as a faculty speaker or as the chair of the session. And the responsibility of the chair is to ensure that it flows well and that the talks are succinct based on what the agenda or the objectives were as defined by the education committee for that specific group. But that was it. So really being named “Chair” was sort of an honor, an honorific. It really didn't come with responsibility. So, we use the Ed Book as a way to say, “As chair of the session, it is your responsibility to ensure A, a manuscript comes to me, but B, that the content of that paper harmonizes and is accurate.” And it was very rare, but Nate, I think we got dragged into a couple of times where the accuracy of the manuscript was really called into question by the chair. And those were always very, very tricky discussions because everyone that gets invited to ASCO is a recognized leader in their field. Some of us, especially, I would probably say, dating back 10 years from today, the data behind Standards of Care were not necessarily evidence-based. So, there were a lot of opinion-based therapies. You know, maybe not so much in the medical side, but certainly some of it. But when you went to, you know, surgical treatments and maybe even radiotherapy treatments, it was really based on, “My experience at my center is this and this is why I do what I do.” But those kinds of things ended up being some of the more challenging things to handle as an editor. Dr. Nathan Pennell: And those are the– I'll use “fun” in a broad sense. You know, every once in a while, you get an article where it really does take a lot of hands-on work from the editor to work with the author to try to revise it and make it a suitable academic manuscript. But you know what? I can't think, at least in recent years, of any manuscripts that we turned down. They just sometimes needed a little TLC. Dr. Don Dizon: Yeah. And I think the other important thing it reminds me of is how great it was that I wasn't doing this by myself. Because it was so great to be able to reach out to you and say, “Can you give me your take on this paper?” Or, “Can you help me just join a conference call with the authors to make sure that we're on the same page?” And then on the rare example where we were going to reject a paper, it was really important that we, as the editorial team, and I include our ASCO shepherder, through the whole process. We had to all agree that this was not salvageable. Fortunately, it happened very rarely. But I've got to say, not doing this job alone was one of the more important facets of being the EIC of ASCO's Educational Book. Dr. Nathan Pennell: Well, it's nice to hear you say that. I definitely felt that this was a partnership, you know, it was a labor of love. So, I want to go to what I consider sort of the third major pillar of the changes to the Ed Book during your tenure, and that was the introduction of a whole new kind of manuscript. So up to, I don't know, maybe seven or eight years ago, all the articles were authored just by people who were presenting at the Annual Meeting. And then you had an idea to introduce invited manuscripts. So take me through that. Dr. Don Dizon: Yeah, well, you know, again, it went to this sort of, what can people who are being asked to sort of lead ASCO for that year, what can they demonstrate as sort of a more tangible contribution to the Society and to oncology in general? And I think that was the impetus to use the Ed Book for everyone who was in a leadership position to make their mark. That said, I was here, and I was either president of the society or I was Education Program Chair or Scientific Program Chair, and they got to select an article type that was not being covered in the annual meeting and suggest the authors and work with those authors to construct a manuscript. Never did any one of those folks suggest themselves, which I thought was fascinating. They didn't say, “I want to be the one to write this piece,” because this was never meant to be a presidential speech or a commemorative speech or opportunity for them as leaders. But we wanted to ensure that whatever passion they had within oncology was represented in the book. And again, it was this sort of sense of, I want everyone to look at the Ed Book and see themselves in it and see what they contributed. And that was really important for those who were really shepherding each Annual Meeting each year for ASCO that they had the opportunity to do that. And I was really pleased that leadership really took to that idea and were very excited about bringing ideas and also author groups into the Educational Book who would not have had the opportunity otherwise. I thought that was just really nice. It was about inclusiveness and just making sure that people had the opportunity to say, “If you want to participate, we want you to participate.” Dr. Nathan Pennell: Yeah, I agree. I think the ASCO leadership jumped on this and continues to still really appreciate the opportunity to be able to kind of invite someone on a topic that's meaningful to them. I think we've tried to work in things that incorporate the presidential theme each year in our invited manuscript, so it really allows them to put kind of a stamp on the flavor of each edition. And the numbers reflect that these tend to be among our more highly read articles as well. Dr. Don Dizon: You know, looking back on what we did together, that was something I'm really, really quite proud of, that we were able to sort of help the Educational Book evolve that way. Dr. Nathan Pennell: I agree. You brought up briefly a few minutes ago about social media and its role over time. I think when we started in 2012, I had just joined Twitter now X in 2011, and I think we were both sort of early adopters in the social media. Do you feel like social media has had a role in the growth of the Ed Book or is this something that you think we can develop further? Dr. Don Dizon: When we were doing Ed Book together, professional social media was actually a quite identified space. You know, we were all on the same platform. We analyzed what the outcomes were on that platform and our communities gathered on that platform. So, it was a really good place to highlight what we were publishing, especially as we went to continuous publishing.  I don't remember if it was you or me, but we even started asking our authors for a tweet and those tweets needed work. It was you. It was you or I would actually lay in these tweets to say, “Yeah, we need to just, you know, work on this.” But I think it's harder today. There's no one preferred platform. Alternate platforms are still evolving. So, I think there are opportunities there. The question is: Is that opportunity meaningful enough for the Ed Book to demonstrate its return on an investment, for example? What I always thought about social media, and it's still true today, is that it will get eyes on whatever you're looking at far beyond who you intended to see it. So, you know, your tweets regarding a phase 3 clinical trial in lung cancer, which were so informative, were reaching me, who was not a lung oncologist who doesn't even see lung cancer and getting me more interested in finding that article and more and more pointing to the Educational Book content that speaks to that piece, you know. And I think coupling an impression of the data, associating that with something that is freely accessed is, I think, a golden opportunity not only for our colleagues, but also for anyone who's interested in a topic. Whether you are diagnosed with that cancer or you are taking care of someone with that cancer, or you heard about that cancer, there are people who would like to see information that is relevant and embedded and delivered by people who know what they're talking about. And I think our voices on social media are important because of it. And I think that's where the contribution is. So, if we had to see what the metric was for any social media efforts, it has to be more of the click rates, not just by ASCO members, but the click rates across societies and across countries. Dr. Nathan Pennell: Yeah, social media is, I mean, obviously evolving quite a bit in the last couple of years. But I do know that in terms the alt metrics for the track access through social media and online, the ones that are shared online by the authors, by the Ed Book team, do seem to get more attention. I think a lot of people don't like to just sit with a print journal anymore or an email table of contents for specific journals. People find these articles that are meaningful to them through their network and oftentimes that is online on social media. Dr. Don Dizon: Yes, 100%. And you know what I think we should encourage people to do is look at the source. And if the Ed Book becomes a source of information, I think that will be a plus to the conversations in our world. We're still dealing with a place where, depending on who sponsored the trial, whether it was an industry-sponsored trial, whether it was NCI sponsored or sponsored by the National Institutes of Health, for example, access to the primary data sets may or may not be available across the world, but the Ed Book is. And if the Ed Book can summarize that data and use terms and words that are accessible no matter what your grade level of education is. If we can explain the graphs and the figures in a way that people can actually easily more understand it. If there's a way that we structure our conversations in the Ed Book so that the plethora of inclusion/exclusion criteria are summarized and simplified, then I think we can achieve a place where good information becomes more accessible, and we can point to a summary of the source data in places where the source is not available. Dr. Nathan Pennell: One of the other things that I continue to be surprised at how popular these podcasts are. And that gives you an opportunity pretty much the opposite. Instead of sort of a nugget that directs you to the source material, you've got a more in-depth discussion of the manuscript. And so, I'm delighted that we have our own podcast. For many years, the Ed Book would sort of do a sort of a “Weird Al takeover” of the ASCO Daily News Podcast for a couple of episodes around the Annual Meeting, and I think those were always really popular enough that we were able to argue that we deserved our own podcast. And I'm really looking forward to having these in-depth discussions with authors. Dr. Don Dizon: It's an amazing evolution of where the Ed Book has gone, right? We took it from print only, societally only, to something that is now accessed worldwide via PubMed. We took it from book to fully online print. And now I think making the content live is a natural next step. So, I applaud you for doing the podcast and giving people an opportunity actually to discuss what their article discusses. And if there's a controversial point, giving them the freedom and the opportunity to sort of give more nuanced views on what may not be something that there's 100% consensus over. Dr. Nathan Pennell: Yes. Well, I hope other people enjoy these as well. Just want to highlight a few of the things that have happened just in the couple years since you stepped down as editor-in-chief. One of them, and I don't know if you noticed, but last year we started adding manuscripts from the ASCO thematic meetings, so ASCO GI and ASCO GU, something we had certainly talked about in the past, but had lacked bandwidth to really do. And they seem to be pretty widely accessed. Dr. Don Dizon: That's fantastic. Yes, I do remember talking about the coverage of the thematic meetings and you're right, this takes a long time to sort of concentrate on the Annual Meeting. It may seem like everything happens in the span of like eight weeks. Dr. Nathan Pennell: It does feel like that sometimes. Dr. Don Dizon: Right? But this is actually something that starts a year before, once the education program is set. We're in the room when they set it. But then it's really chasing down manuscripts and then making sure that they're peer reviewed because the peer review is still really important, and then making sure that any revisions are made before it's finalized and goes to press. That is a many months process. So, when we're trying to introduce, “Oh, we should also do ASCO GU or-,” the question was, how do you want to do that given this very, very involved process going forward? So, I'm glad you were able to figure it out. Dr. Nathan Pennell: Well, it's challenging. I don't think people realize quite the compressed timeline for these. You know, the Education Session and authors and invited faculty are picked in the fall, and then basically you have to start turning in your manuscripts in February, March of the following year. And so, it's a really tight turnaround for this. When we talk about the ASCO thematic meetings, it's an even tighter window. Dr. Don Dizon: Right, exactly. Dr. Nathan Pennell: And so, it's challenging to get that moving, but I was really, really proud that we were able to pull that off. Dr. Don Dizon: Well, congratulations again. And I think that is a necessary step, because so much of what's going on in the various disease management sites is only covered cursorily through the Annual Meeting itself. I mean, there's just so much science breaking at any one time that I think if we want to comprehensively catalog the Year in Review in oncology, it kind of behooves us to do that. Dr. Nathan Pennell: Some other things that are coming up because we now have manuscripts that are going to be coming in year-round, and just to kind of make it easier on the editorial staff, we're going to be forming an editorial board. And in addition to our pool of reviewers who get ASCO points, please feel free to go online to the ASCO volunteer portal and sign up if you are interested in participating. So, moving forward, I'm really excited to see where things are going to go. Dr. Don Dizon: Well, that's great. That's great. And I do remember talking about whether or not we needed to have an editorial board. At least when I was there, having this carried by three people was always better than having it carried by one person. And I think as you expand the potential for submissions, it will be very helpful to have that input for sure. And then it gives another opportunity for more members to get involved in ASCO as well. Dr. Nathan Pennell: Absolutely. People want involvement, and so happy to provide that. Dr. Don Dizon: Yes. Dr. Nathan Pennell: Is there anything we didn't cover that you would like to mention before we wrap up? Dr. Don Dizon: Well, I will say this, that ASCO and through its publications not only has had this real emphasis on multidisciplinary management of cancers, especially where it was relevant, but it also always had a stand to ensure representation was front and center and who wrote for us. And I think every president, every chair that I've worked with naturally embraced that idea of representation. And I think it has been a distinct honor to say that during my tenure as EIC, we have always had a plethora of voices, of authors from different countries, of genders, that have participated in the construction of those books. And it stands as a testament that we are a global community and we will always be one. Dr. Nathan Pennell: Well, thank you for that. And I'm happy to continue that as we move forward. Well, Don, thank you. It's been great speaking with you. You played such a pivotal role in the Ed Book's evolution and I'm so glad you were able to join me for our inaugural episode. Dr. Don Dizon: Well, I'm just tickled that you asked me to be your first guest. Thank you so much, Nate. Dr. Nathan Pennell: And I also want to thank our listeners for joining us today. We hope you'll join us again for more insightful views on topics you'll be hearing at the Education Sessions from ASCO meetings throughout the year, as well as our periodic deep dives on advances that are shaping modern oncology. Have a great day. Disclaimer: The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience and conclusions. Guest statements on the podcast do not express the opinions of ASCO. The mention of any product, service, organization, activity or therapy should not be construed as an ASCO endorsement. Follow today's speakers:   Dr. Nathan Pennell  @n8pennell @n8pennell.bsky.social   Dr. Don Dizon @drdondizon.bsky.social  Follow ASCO on social media:   @ASCO on X (formerly Twitter)   ASCO on Bluesky  ASCO on Facebook   ASCO on LinkedIn   Disclosures:  Dr. Nathan Pennell:      Consulting or Advisory Role: AstraZeneca, Lilly, Cota Healthcare, Merck, Bristol-Myers Squibb, Genentech, Amgen, G1 Therapeutics, Pfizer, Boehringer Ingelheim, Viosera, Xencor, Mirati Therapeutics, Janssen Oncology, Sanofi/Regeneron     Research Funding (Inst): Genentech, AstraZeneca, Merck, Loxo, Altor BioScience, Spectrum Pharmaceuticals, Bristol-Myers Squibb, Jounce Therapeutics, Mirati Therapeutics, Heat Biologics, WindMIL, Sanofi  Dr. Don Dizon: Stock and Other Ownership Interests: Midi, Doximity Honoraria: UpToDate, American Cancer Society Consulting or Advisory Role: AstraZeneca, Clovis Oncology, Kronos Bio, Immunogen Research Funding (Institution): Bristol-Myers Squibb          

NEWS: Dizon: privatizing policies to continue | Feb. 25, 2025Visit our website at https://www.manilatimes.netFollow us:Facebook - https://tmt.ph/facebookInstagram - https://tmt.ph/instagramTwitter - https://tmt.ph/twitterDailyMotion - https://tmt.ph/dailymotionSubscribe to our Digital Edition - https://tmt.ph/digitalSign up to our newsletters: https://tmt.ph/newslettersCheck out our Podcasts:Spotify - https://tmt.ph/spotifyApple Podcasts - https://tmt.ph/applepodcastsAmazon Music - https://tmt.ph/amazonmusicDeezer: https://tmt.ph/deezerStitcher: https://tmt.ph/stitcherTune In: https://tmt.ph/tunein#TheManilaTimes Hosted on Acast. See acast.com/privacy for more information.

NEWS: Bautista out, Dizon in as transport chief | Feb. 14, 2025Visit our website at https://www.manilatimes.netFollow us:Facebook - https://tmt.ph/facebookInstagram - https://tmt.ph/instagramTwitter - https://tmt.ph/twitterDailyMotion - https://tmt.ph/dailymotionSubscribe to our Digital Edition - https://tmt.ph/digitalSign up to our newsletters: https://tmt.ph/newslettersCheck out our Podcasts:Spotify - https://tmt.ph/spotifyApple Podcasts - https://tmt.ph/applepodcastsAmazon Music - https://tmt.ph/amazonmusicDeezer: https://tmt.ph/deezerStitcher: https://tmt.ph/stitcherTune In: https://tmt.ph/tunein#TheManilaTimes Hosted on Acast. See acast.com/privacy for more information.

At the 2024 San Antonio Breast Cancer Symposium Dr. Don Dizon, professor of medicine and professor of surgery at the Brown University Cancer Institute, was part of a panel entitled “Sex, Drugs, and Rock and Roll.” His presentation focused on sexual health after breast cancer. Listen to the episode to hear Dr. Dizon discuss: the highlights of his presentation why sexual health after cancer treatment is important his advice on how to discuss sexual health with a provider, especially for people in the LGBTQ+ community

Nakatadhana na ba ang buhay at personality mo based sa zodiac sign mo? Explain namin yan in just 8 minutes kasama si Charlie Dizon! Tune in na Silly Gang Express!Listen to the full episode HERE!Watch the EXCLUSIVE VIDCAST HERE!CERTIFIED KA-OKRA TO DO LIST:TAP the FOLLOW button and NOTIFICATION BELL!RATE this podcast with 5 STARS! ⭐⭐⭐⭐⭐JOIN THE CONVO via the POLL here on SPOTIFY app! Scroll down mo lang sa Spotify app!Drop your voice over intros HERE!Follow us here:Silly Gang Sa Gabi on Facebook, Twitter, Instagram, YouTube and Tiktok!For brand deals (beke nemen!) and collaborations (G!), connect with us through sillygangsagabi@gmail.com and/or our management: info@thepodnetwork.com! Hosted on Acast. See acast.com/privacy for more information.

August 29, 2024 Noel Raboy, the President and CEO, along with Donna Dizon, the VP for Administration & Corporate Planning at CLIMBS Life and General Insurance Cooperative, explore the structure and benefits of Cooperative Insurance. CLIMBS Life and General Insurance Cooperative is a leading cooperative insurance organization based in the Philippines. Established in 1971, it provides life and non-life insurance products and services tailored primarily to cooperatives, cooperative members, and their families. Owned by almost 5,000 cooperatives nationwide, its mission is to provide affordable and accessible insurance coverage to its members, particularly focusing on the needs of the grassroots community. Over the years, CLIMBS has expanded its services to include a range of insurance products and other financial services. With innovation, it is the first and the only provider of a parametric insurance in the Philippines that covers cooperatives, benefiting over 100,000 households of farmer-members since its flagship offering in 2021. CLIMBS is also at the forefront of advocacy work especially on Climate Action and strengthening of the movement and promoting cooperative education locally and globally. It emphasizes cooperative values and social responsibility, aiming to contribute to the economic and social development of its members and the communities they serve.

It is such a priviledge to get to know Alain and also Marlo who got freed from the bondage of sin. Freedom from sin is truly liberating as witness in the lives of these men. Support CBN Asia today!https://www.cbnasia.com/giveSupport the Show.

Alain offered his desires of the flesh to God when he remembered Mark 8:34 which he had read in the Bible. That moment signaled Alain's heartfelt surrender of his life to the Lord and his complete departure from his former way of life. He also encountered people who would help and guide him on the new path he was taking. Support CBN Asia today!https://www.cbnasia.com/giveSupport the Show.

Isn't it ironic?  Pumunta ka sa duktor mo para humingi ng gamot para mamatay ka na.  And you got your wish.  Namatay ka nga, sa iyong kasalanan when you surrendered your life to Christ.  But at the same time, you experienced a rebirth in your spirit.Support CBN Asia today!https://www.cbnasia.com/giveSupport the Show.

Sinamahan si Alain ng kanyang ama sa panahon ng kanyang gamutan.  Sa gamutan kinakailangan ni Alain na manatili doon ng 14 days para ma-obersahan ang mga side effects ng gamot.  At sa mga panahong iyon ay na-appreciate ni Alain ang pagmamahal ng kanyang ama. Support CBN Asia today!https://www.cbnasia.com/giveSupport the Show.

Alain was in Grade 5 when he started having crushes with the same sex.  He tried to hide it because he heard from the church that gays go straight to hell. Moreover, he knew he would be condemned by people.  Alain was closer to his mother than to his father who was strict and verbally abusive. But despite his gay tendency, he had a crush on a girl in elementary until High School. He prayed to God that if the girl would be his wife, he would build a family with her. But that didn't happen. Support CBN Asia today!https://www.cbnasia.com/giveSupport the Show.

DEBATE: Is Transubstantiation True? (Dizon vs. Glover)

In this episode, Gabby Dizon, Co-Founder of Yield Guild Games (YGG), shares his journey from PC gamer to Web3 pioneer. He discusses the challenges and future of Web3 gaming, highlighting AI's potential impact and the qualities needed for founders to succeed. Learn about YGG's evolution, their innovative on-chain guilds, and the key to mainstream adoption of Web3 games. Gabby Dizon is a game industry veteran with over 18 years of experience. He co-founded Yield Guild Games, a play-to-earn gaming guild and decentralized autonomous organization (DAO) that provides gamers all over the world an opportunity to access the NFT game assets needed to start playing blockchain games and earn crypto-based rewards. He is also a founding board member of the Blockchain Game Alliance. Gabby's mission is to onboard millions of gamers so they can find opportunities in the digital world. He believes that the future of work is in the open Metaverse. We hope you enjoy Gabby's conversation with hosts Kenzi Wang, Sachi Kamiya, and Diksha Dutta, where he talks in-depth about his Web3 founder journey.

DEBATE: Is Baptismal Regeneration Biblical? (Dizon vs. Glover)

Who could ever believe that a hustler-since-childhood selling whatnots to her classmates in Pampanga and college dropout hawking ukay-ukay clothes, soap, and eventually, makeup could build a cosmetics empire now worth over $2 Million? Ten years ago, not many people did, and often, the only one who believed in and rooted for Colourette Cosmetics CEO Nina Dizon was herself. Her journey from a one-girl team no one took seriously to a celebrated venture capital-funded entrepreneur and almost 2 Million-follower social media influencer is a testament to her unwavering self-belief and determination to succeed. Get inspired to become your own biggest cheerleader as she shares her experiences, epiphanies, and advice. Nina is also the co-author of her memoir Rooting For Me: Breaking Boundaries as a Businesswoman.

Gabby Dizon is the Co-Founder of Yield Guild Games (YGG), a decentralized autonomous organization that invests in virtual world assets. Yield Guild Games focuses on creating a global community of gamers who earn rewards by playing blockchain-based games. YGG operates on the play-to-earn model, allowing players to generate income through in-game activities and ownership of digital assets. 0:00 Intro 1:23 Yield Guild Games 4:34 New Games 5:42 Gabby Dizon 8:39 Ronin 10:21 YGG Token 15:30 Criticisms 18:05 Protocol Transition 24:15 Onchain Guilds 33:33 Badges and Onchain Reputation 40:25 Gaming and NFT Activity 44:40 Building in 2024 48:35 Mass Applications Our sponsor https://stellar.org/soroban?utm_source=defiant&utm_medium=cpc&utm_campaign=defiant_podcast https://www.karpatkey.com/?utm_source=Youtube_des&utm_medium=podcast&utm_campaign=Defiant ✨ Check out our new website ✨ https://thedefiant.io/

On SBS Filipino's Trending Ngayon segment, various celebrities and personalities including Miss Universe Philippines 2024 Chelsea Manalo, attended the June 12 Philippine Independence Day celebration in Manila; 'Taxi Cab Theory' a perspective familiar among men these days?; and the sudden wedding of seasoned actor Carlo Aquino to his most recent girlfriend, actress Charlie Dizon shocked netizens. - Sa Trending Ngayon ng SBS Filipino, selebrasyon ng kasarinlan ng Pilipinas sa Maynila dinaluhan ng iba't ibang personalidad kasama si Miss Universe Philippines 2024 Chelsea Manalo, 'taxi cab theory' tunay bang may mga kalalakihan na pasok sa teoryang ito?, at biglaang kasal ng aktor na si Carlo Aquino sa bago pa lamang na nobya na si Charlie Dizon ikinagulat ng marami.

Luis Dizon covers this coming Sunday’s lectionary readings and explains why Jesus spoke in parables.

At long last we finally have on the show a priest whose voice is heard by thousands every day through Hallow and his own successful online ministry: Sa Madaling Sabi (SMS). Pero higit pa dito, tunay ko syang hinangaan ng malamang siya ay isang chaplain ng COURAGE Ph, a Catholic ministry for those with Same-Sex Attraction or who identify as other genders. Malaman, makulay, at masaya—isang ka-abang abang na episode na naman ng PadsCast kasama ang nag-iisang Fr. Franz Dizon.

NEWS: Carlo Aquino, Charlie Dizon tie knot | June 10, 2024Subscribe to The Manila Times Channel - https://tmt.ph/YTSubscribe Visit our website at https://www.manilatimes.net Follow us:Facebook - https://tmt.ph/facebookInstagram - https://tmt.ph/instagramTwitter - https://tmt.ph/twitterDailyMotion - https://tmt.ph/dailymotion Subscribe to our Digital Edition - https://tmt.ph/digital Check out our Podcasts:Spotify - https://tmt.ph/spotifyApple Podcasts - https://tmt.ph/applepodcastsAmazon Music - https://tmt.ph/amazonmusicDeezer: https://tmt.ph/deezerStitcher: https://tmt.ph/stitcherTune In: https://tmt.ph/tuneinSoundcloud: https://tmt.ph/soundcloud#TheManilaTimes Hosted on Acast. See acast.com/privacy for more information.

As Eric notes at the end of today's podcast, we talk about many difficult issues with our patients.  How long they might have to live. Their declining cognitive abilities. What makes their lives meaningful, brings them joy, a sense of purpose.  But one issue we're not as good at discussing with our patients is sexual health. On today's podcast Areej El-Jawahri, oncologist specializing in blood cancers at MGH, says that sexual health is one of the top if not the top issue among cancer survivors.  Clearly this issue is important to patients.  Sharon Bober, clinical psychologist at DFCI, notes that clinicians can get caught in an anxiety cycle, in which they are afraid to ask, don't ask, then have increased anxiety about not asking.  Like any other conversation, you have to start, and through experience learn what language is comfortable for you.  Don Dizon, oncologist specializing in pelvic malignancies at Brown, suggests speaking in plain language, starting by normalizing sexual health issues, to paraphrase, “Many of my patients experience issues with intimacy and sexual health. Is that an issue for you? I'm happy to talk about it at any time.”  All guests agree that clinicians feel they need to have something they can do if they open Pandora's box.  To that end, we talk about practical advice, including: The importance of intimacy over and above physical sexual function for many patients Common causes and differential diagnoses of sexual concerns in patients with cancer and survivors Treatments for erectile dysfunction - first time the words “cock ring” have been uttered on the GeriPal Podcast - and discuss daily phosphodiesterase 5 inhibitor therapy vs prn The importance of a pelvic exam for women experiencing pain What is “pelvic physical therapy?” Treatments for vaginal dryness and atrophy ACS links, NCCN links, Cancersexnetwork, and a great handout that Areej created And I get to sing Lady Gaga, also a first for GeriPal!  And let me tell you, there's nothing like the first time (sorry, I couldn't help it!).

In today's episode Jason sits down with Yield Guild Games Co-Founder Gabby Dizon! Gabby discusses YGG's origin story, the future of P2E, and scholarships. As well as how YGG reviews the Web3 gaming landscape, Gabby's lessons from his days in Web2 gaming, plus Gabby shares his top up and coming Web3 games! To finish, Jason and Gabby discuss the Guild Protocol, quest elements and upcoming integrations for YGG, future verticals, and much more—enjoy! Host: Jason Choi @mrjasonchoi . Not financial advice.   Timestamps: (00:00) Introduction (03:20) YGG origin (08:06) Play-to-earn and scholarships (10:13) Guild success (12:32) Gaming ecosystem analysis (17:19) Lessons learned from Web2 (20:13) Up and coming Web3 games (21:22) Guild protocol (29:54) Quest elements & community integration (33:11) Other verticals (36:45) Potential threats to YGG (38:42) YGG's roadmap (40:22) Outro   Yield Guild Games (YGG) is a web3 guild protocol that enables players and gaming guilds to find their community, discover games and level up together. Its mission is to become the leading community-based user acquisition platform in web3 gaming through fun quests that help players build their onchain reputation Find out more at https://investors.yieldguild.io/   Twitter accounts: Jason Choi's Twitter: https://twitter.com/mrjasonchoi   Gabby Dizon's Twitter: https://x.com/gabusch YGG Twitter: https://x.com/YieldGuild Blockcrunch VIP: https://blockcrunch.substack.com/ Blockcrunch Twitter:   https://twitter.com/theBlockcrunch   Disclaimer: The Blockcrunch Podcast (“Blockcrunch”) is an educational resource intended for informational purposes only. Blockcrunch produces a weekly podcast and newsletter that routinely covers projects in Web 3 and may discuss assets that the host or its guests have financial exposure to. Views held by Blockcrunch's guests are their own. None of Blockcrunch, its registered entity or any of its affiliated personnel are licensed to provide any type of financial advice, and nothing on Blockcrunch's podcast, newsletter, website and social media should be construed as financial advice. Blockcrunch also receives compensation from its sponsor; sponsorship messages do not constitute financial advice or endorsement.   Full disclaimer:  https://blockcrunch.substack.com/about

Dr. Javad Hashmi talks about Islamic Modernism and how it differs from traditional perspectives on Islam.

Japan is strategically positioning itself as a global leader in Web3. While lawmakers and regulators in the U.S., Europe, and other countries in Asia have adopted a cautious stance towards cryptocurrency, Japan continues to boldly champion the advancement of Web3 as a pivotal component of its national strategy.Lani Dizon is the co-founder of Zenza Capital and the innovative RYO project, Japan's first Layer-1 blockchain launch. In our conversation, we explore how RYO aims to simplify cryptocurrency for mass adoption.⚠️

Luis Dizon and Michael Lofton review the discussion between a Unitarian and a Trinitarian on the topic: Is Jesus God?

Michael Lofton and Luis Dizon interview Dr. Bart Ehrman (New Testament Scholar) and Dr. Javad Hashmi (Islamic Scholar) on comparing historical problems between the Bible and the Quran. Lofton and Dizon will soon take the course and then provide a critical review from a Catholic perspective.

With over three decades of experience in global business development, branding, marketing, and product development, Lani has empowered individuals worldwide in entrepreneurship, health, wealth, and personal development. From building her first distribution network of 120,000 people by age 20 to co-founding multiple companies spanning health, beauty, personal development, and women's empowerment, she has established herself as a leader in diverse industries. Additionally, as a Co-Founder of Zenza Capital and the RYO Project, pioneering cryptocurrency and blockchain ventures, she continues to drive innovation and cryptocurrency adoption through groundbreaking initiatives like the first Layer-One Blockchain launching from Japan, incorporating a comprehensive Web3 ecosystem.StreamSpotifyApple Podcast Support The ShowMerchPatreonSocial Media FacebookLinkedInInstagramTikTokYouTube

San Antonio entrepreneurs and startups often find themselves meeting with Cat Dizon, the chief operating officer at venture capital firm Active Capital and the chairwoman of the Geekdom board. The former senior Rackspace executive is the gatekeeper to San Antonio's leading seed fund, and is always on the lookout for young, promising businesses.  

Catholic Bible Study (Sunday Lectionary Readings) w/ Luis Dizon

Lectionary Readings: Fifth Sunday of Lent (Year B) w/ Luis Dizon

With in-person legal conferences returning, legal nurse consultants again have access to a valuable resource for connecting with potential attorney clients via an exhibit. Pat Iyer, a veteran conference vendor, shares what she's learned during her decades of exhibiting at such events. A conference that will have fewer than 100 attendees is usually not worth your while. You also have to determine if the attendees will represent your target audience. In addition, you want to know what kind of material support you will get from the organizers. Good organizers recognize that vendors' fees help to make a conference possible. Pat goes into detail about what makes an attractive giveaway. Ideally, it's something an attorney will use and keep on their desk. You need to consider cost, ease of transport, and other factors in choosing this item. She has found that a one-day event is much easier to organize, more affordable, and has a more focused impact than a multi-day event. It also helps your bottom line if the event is within driving distance. Pat also goes into security considerations for protecting your merchandise for an event longer than a day. She emphasizes the need to secure business cards you collect and discusses other practical considerations. Pat will be giving a workshop on the subject of exhibiting at an upcoming virtual conference in March. You can find registration information towards the end of this podcast. Be sure to study this podcast and gain knowledge about this essential marketing tool Learn More About Planning an Exhibit - Tips for LNCs Pat Iyer and Jennifer Dizon What is the minimum number of attendees that make a conference worthwhile? Why is it important to learn how the organizers of the conference support and help vendors? What are some attractive giveaways? How do you plan differently for a one-day versus a multi-day event? Why is it valuable to network with other exhibitors? Listen to our podcasts or watch them using our app, Expert.edu, available at legalnursebusiness.com/expertedu. We want to hear from you! Click the red send voicemail button on the far right. (function(d){ var app = d.createElement('script'); app.type = 'text/javascript'; app.async = true; app.src = 'https://www.speakpipe.com/loader/laulw5fck6uczyhl834u7d3jfzpe7xy5.js'; var s = d.getElementsByTagName('script')[0]; s.parentNode.insertBefore(app, s); })(document); Get the free transcripts and also learn about other ways to subscribe. Go to Legal Nurse Podcasts subscribe options by using this short link: http://LNC.tips/subscribepodcast. https://youtu.be/Btor0_oJIs0 Join us for a 3-day virtual event designed for legal nurse consultants just like you LNC Success™ Pat Iyer and Barbara Levin put together THE first Legal Nurse Consulting Virtual Conference in July 2020. They are back with their 9th all-new conference based on what attendees said they'd find most valuable. The LNC Success Conference implementation and also networking event is designed for LNCs at any stage in their career. Build your expertise, also attract higher-paying attorney clients, and take your business to the next level. After the LNC Success™ Virtual Conference, you will leave with clarity, confidence, and also an effective step-by-step action plan that you can immediately implement in your business. Your Presenter of Planning an Exhibit - Tips for LNCs Pat Iyer and Jennifer Dizon Pat Iyer founded, grew and sold a successful legal nurse consulting business that had annual sales in the 7 figures. She is a well-known, respected expert in the field of legal nurse consulting. She has written, edited, or coauthored over 800 chapters, books, case studies, online courses or articles about the topic of legal nurse consulting. Pat served on the board of directors of the American Association of Legal Nurse Consultants for 5 years including a year as President of the ...

Luis Dizon covers the Book of Ezekiel from a Catholic perspective.

Catholic Bible Study Stream: Year B, 3rd Sunday in Ordinary Time w/ Luis Dizon)

A Catholic Commentary on the Book of Lamentations and Baruch w/ Luis Dizon

”In a society that glorifies titles, visibility, reach, and the grind, taking a beat to opt out of all that isn't easy,” today's guest Mel Dizon writes in the origin story to her pop-up Substack. Mel shares how she defines an accidental sabbatical; the energetic urgency and pent up ambition that let her know it was time to leave her job; the permission she needed to give herself; navigating the fears that followed; how publishing her process out loud has helped with courage and accountability; and trusting herself to make important decisions when it's time, while also not rushing that process. More About Mel: Mel Dizon is a writer and editor; a runner, CrossFitter, pickleballer, and efficiency fanatic; a former therapist, consultant, and coach; a dog, pool, and scalding-hot-dirty-chai lover. She started writing words for dollars back in 1993. She's written thousands of articles, ghostwritten many books and essays, facilitated hundreds of video interviews, and written copy for everyone from NYT best-selling authors to companies like Google. Melani dreamed about taking a sabbatical for years, and the universe finally conspired to light the way. Turns out she's a big fan. She currently writes life & dying on Substack for those in the middle of the reinvention mess, seeking to “live a life worth writing about.”

Gabby Dizon, Cofounder of Yield Guild Games, and Jeremy Au talked about three main themes: 1. Founding Yield Guild Games (YGG): Gabby reflected on his childhood passion for computer games which led him to a career in game development and startups. He shared how he first met his cofounders Beryl Li and Owl of Moistness online, and how his CTO maintained his anonymity during a later $4.6M funding round from Andreessen Horowitz (a16z). 2. Web3, Gaming & Crypto Industry: He delved into the cyclical bull-and-bear nature of crypto, and the contrasting roles of good and bad actors. He also discussed digital scarcity and how it applies to the gaming world, emphasizing the parallels with physical assets and trading. He also discussed YGG's strategic evolution from an asset lending model to a more comprehensive system involving quests, achievement platforms, and the integration of real-world applications like credentials. 3. Generational Shifts: Gabby spoke about the importance of bridging the gap between millennials, Gen Z, and future generations. He underscored the founder's responsibility of reshaping the world and normalizing new technologies and connects this to his personal experience as a father who is comfortable discussing with his children about Web3 as a place for learning and experimentation. They also talked about the future of work and the relevance of traditional education, how content consumption influences actions, and the impact of communities in the crypto and gaming sectors. Watch, listen or read the full insight at https://www.bravesea.com/blog/gabby-dizon Get transcripts, startup resources & community discussions at www.bravesea.com WhatsApp: https://chat.whatsapp.com/CeL3ywi7yOWFd8HTo6yzde Spotify: https://open.spotify.com/show/4TnqkaWpTT181lMA8xNu0T YouTube: https://www.youtube.com/@JeremyAu Apple Podcasts: https://podcasts.apple.com/sg/podcast/brave-southeast-asia-tech-singapore-indonesia-vietnam/id1506890464 Google Podcasts: https://podcasts.google.com/feed/aHR0cHM6Ly9mZWVkLnBvZC5jby9icmF2ZWR5bmFtaWNz TikTok: https://www.tiktok.com/@jeremyau Instagram: https://www.instagram.com/jeremyauz Twitter: https://twitter.com/jeremyau LinkedIn: https://www.linkedin.com/company/bravesea Learn more about Acme Technology here: https://www.tryacme.com

The boys had a blast recording with our guest Ronnie Dizon, Ronnie gives some great insight and has some great stories up his sleeve, including answering how Heat would do against the grizzly bear. XXV (Merch) Link: https://xxvthelabel.com/collections/mafia-productions Use Code "FTS" at www.Weltzclothing.com Get 20% off and free shipping at liquidIV.com using code "Mafia_Moffitt" Buy 2 get 1 free at NECTR.energy/Mafiaproductions with Code "MafiaProductions" Find us on YouTube: Mafia Productions Instagram: @Mafia_Moffitt

Dale Glover and Luis Dizon talk about Old Testament prophecies that point to Jesus as the messianic fulfillment.

Episode 366 - S14 E07 Tarot Master - Marvin Dizon #OAGOT

Is the Shroud of Turin really the burial cloth of Jesus after his crucifixion? Dale Glover and Luis Dizon join Reason & Theology to discuss the matter with a detailed presentation!

Catholic Commentary of the Book of Sirach w/ Luis Dizon

In this episode, hosts Shikha Jain, MD, Douglas H. Jones, MD, Amy Comander, MD, Dagny Zhu, MD, Don Dizon, MD, and Mark A. Lewis, MD, discuss the new social media platform, Threads and how physicians can use it for their practice. •    Welcome to another exciting episode of Oncology Overdrive :57 •    The topic 1:10 •    How many have created a profile on Threads? Why or why not? 2:59 •    Dr. Jain has a Thread profile but is unsure how to get more engagement 3:20 •    Dr. Lewis has convinced coworkers to use social media but has not used Threads yet 4:54 •    Dr. Dizon has a Thread profile but notes that leaving other platforms is leaving those communities and starting all over on a new platform 6:25 •    Giving Threads more time to pick up followers and engagement 11:18  •    Dr. Zhu has a Thread profile and found it easy to create but engagement is not the same as other platforms 12:17 •    Tips and tricks to sharing content on socials, especially Threads 14:33  •    Trouble with other social media platforms 17:55 •    Tips and tricks to building a community on a social media 20:20 •    The power of social media platforms and engagement in established communities 22:30 •    Fighting misinformation 25:13 •    Platforms versus audience 27:15 •    How would you like to see Threads change as a platform? 31:21 •    What is the power of TikTok in terms of getting movement among communities? 33:31 •    How do you create a profile on Threads? 40:30 •    Level of engagement: Twitter vs. Threads 43:31 •    The overwhelming number of platforms 52:29 •    What is the best platform for physicians to use? 53:41 •    Sharable content to post across other platforms 55:34 •    Final thoughts 58:09 •    Thanks for listening 1:02:13 Douglas H. Jones, MD, is the cofounder of Global Food Therapy, cofounder and president of Food Allergy Support Team and director of Rocky Mountain Allergy at Tanner Clinic. You can follow him on Threads @drdouglasjones. Amy Comander, MD, DipABLM, is director of breast oncology and survivorship at the Massachusetts General Hospital Cancer Center in Waltham and at Newton-Wellesley, and medical director of the Massachusetts General Hospital Cancer Center in Waltham. She is director of the Lifestyle Medicine Program at the Massachusetts General Hospital Cancer Center. She is also an instructor in medicine at Harvard Medical School. You can follow her on Threads @dramycomander. Shika Jain, MD, FACP, is an associate professor of medicine with tenure in the division of hematology, oncology and cell therapy at the University of Illinois Cancer Center in Chicago. She is the director of communication strategies in medicine and associate director of oncology communication and digital innovation. She also is consulting editor for Healio Women in Oncology, as well as host of Healio's Oncology Overdrive podcast. You can follow her on Threads @shikajainmd. Dagny Zhu, MD, is a cornea, cataract, and refractive surgeon and medical director and partner at NVISION Eye Centers in Rowland Heights, CA. You can follow her on Threads @dzeyemd. Don S. Dizon, MD, FACP, FASCO, is head of community outreach and engagement at the Cancer Center at Brown University and head of the breast and pelvic malignancies program at Lifespan Cancer Institute. You can follow him on Twitter (X) and TikTok @drdonsdizon. Mark A. Lewis, MD, is the director of gastrointestinal oncology at Intermountain Healthcare in Murray, Utah, and a medical oncologist specializing in cancers of the gastrointestinal tract and accessory organs. You can follow him on Twitter (X) @marklewismd. We'd love to hear from you! Send your comments/questions to Dr. Jain at oncologyoverdrive@healio.com. Follow Healio on Twitter and LinkedIn: @HemOncToday and https://www.linkedin.com/company/hemonctoday/. Follow Dr. Jain on Twitter: @ShikhaJainMD. Disclosures: The moderators and panelists report no relevant financial disclosures.

Kayla is a newer skater who's been involved with a lot of big projects recently. We talk about representing women in our sport, skating with her female crew, progression as a newer skater, and more.

Can we pray to the saints? Is prayer to saints necromancy? Can we find prayer to the Saints in the Bible either directly or indirectly? Did Jews believe in prayers to the saints in the Old covenant period? Did the early church fathers pray to the saints? Luis Dizon (Catholic) and David Russell (Protestant) debate […]

Can we pray to the saints? Is prayer to saints necromancy? Can we find prayer to the Saints in the Bible either directly or indirectly? Did Jews believe in prayers to the saints in the Old covenant period? Did the early church fathers pray to the saints? Luis Dizon (Catholic) and David Russell (Protestant) debated […]

In today's episode I sit down with a local worship leader to the Colorado area Ian Dizon. I was so thankful for this episode because Ian hit on two of what we believe to be core pillars to Worship ministries and that is Leadership Clarity and Streamlined Systems. Ian talks about his upbringing as not only a worship leader, but primarily as a servant to his local church and how it's impacted his team. He also shares some of his systems he's integrated to help him plan to be spontaneous. You heard me right and you are not going to want to miss that section of this episode. DON'T FORGET TO RATE AND REVIEW THE PODCAST :) THANK YOU IN ADVANCE Ian's Instagram Apply to Join Worship Ministry School: https://churchfront.me/apply Free Worship and Production Toolkit: https://churchfront.me/toolkit Shop Our Online Courses: https://churchfront.me/courses Join us at the Churchfront Live Conference: https://churchfront.me/conference Beginner Church Sound Course: https://churchfront.me/church-sound Follow Churchfront on Instagram or TikTok: @churchfront Follow on Twitter: @realchurchfront Gear we use to make videos at Churchfront: https://kit.co/churchfront/youtube-setup • • • • • Musicbed SyncID: MB01VWQ69XRQNSN  

The Book of Ecclesiastes: A Catholic Overview w/ Luis Dizon

Ronnie Dizon is a professional paintball player for Houston Heat and producer of the world famous DIZON DOCS! Jesse Stephens is a professional paintball player for San Antonio X-Factor and is looking to have a breakout year. This episode is all about the road to Orlando, the first NXL event of the season! Everyone is making their way to Florida this week to kick off the 2023 season! Come hang with us and get ready with PTG! Get access to our discord here:  https://www.patreon.com/playthegamepodcast?fan_landing=truePTG SHOW SPONSORS:LONE WOLF PAINTBALL: https://www.lonewolfpaintball.comHK ARMY: https://www.hkarmy.com/TRANZFUSE: https://tranzlabs.com/?ref=PLAYTHEGAM...BIO CBD: https://biocellrx.com/ CODE: playthegameICONIC PAINTBALL: https://www.iconicpaintball.com/David Roque: CPA Assistant AHSBIZ@GMAIL.COMSupport the show